Dual Attention Multi-Instance Deep Learning for Alzheimer's Disease Diagnosis With Structural MRI

IEEE Trans Med Imaging. 2021 Sep;40(9):2354-2366. doi: 10.1109/TMI.2021.3077079. Epub 2021 Aug 31.

Abstract

Structural magnetic resonance imaging (sMRI) is widely used for the brain neurological disease diagnosis, which could reflect the variations of brain. However, due to the local brain atrophy, only a few regions in sMRI scans have obvious structural changes, which are highly correlative with pathological features. Hence, the key challenge of sMRI-based brain disease diagnosis is to enhance the identification of discriminative features. To address this issue, we propose a dual attention multi-instance deep learning network (DA-MIDL) for the early diagnosis of Alzheimer's disease (AD) and its prodromal stage mild cognitive impairment (MCI). Specifically, DA-MIDL consists of three primary components: 1) the Patch-Nets with spatial attention blocks for extracting discriminative features within each sMRI patch whilst enhancing the features of abnormally changed micro-structures in the cerebrum, 2) an attention multi-instance learning (MIL) pooling operation for balancing the relative contribution of each patch and yield a global different weighted representation for the whole brain structure, and 3) an attention-aware global classifier for further learning the integral features and making the AD-related classification decisions. Our proposed DA-MIDL model is evaluated on the baseline sMRI scans of 1689 subjects from two independent datasets (i.e., ADNI and AIBL). The experimental results show that our DA-MIDL model can identify discriminative pathological locations and achieve better classification performance in terms of accuracy and generalizability, compared with several state-of-the-art methods.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / diagnostic imaging
  • Attention
  • Brain / diagnostic imaging
  • Cognitive Dysfunction* / diagnostic imaging
  • Deep Learning*
  • Humans
  • Magnetic Resonance Imaging